Clinical Trial Update: Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports safety results for a combined oral contraceptive containing Ethinylestradiol and Drospirenone in dysmenorrhea, covering Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• Ethinylestradiol/Drospirenone (ethinylestradiol; drospirenone)

Snippet

Sponsor: Bayer | Conditions: Dysmenorrhea | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2010-10-01